Home > Analytics > GUJARAT THEMIS BIOSYN

GUJARAT THEMIS BIOSYN
Intrinsic Value | Fundamental Analysis

BOM : 506879     NSE : GUJTHEMIS    
LT :  
    Long Term Analysis
Fundamentals : Good
Valuation : Bad [Stock is Expensive]
Debt : Low
Updated:
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Downward
Price Momentum : Mild Upward
Pledged Shares : None or < 25%
Nov 26,2024
Price(EOD): ₹ 325.95
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
Pharmaceuticals & Drugs
MCap: ₹ 3,552.86 Cr
Value of ₹ 1 Lac invested in GUJARAT THEMIS BIOSYN
on Nov 26,2019 (price: ₹ 6.59)

₹ 1 L

₹ 49.49 L

1W : -0.6% 1M : 9% 1Y : 156.8%
COMMUNITY POLL
for GUJARAT THEMIS BIOSYN
Please provide your vote to see the results
GUJARAT THEMIS BIOSYN is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Industry Peers & Returns1W1M1Y
GUJARAT THEMIS BIOSYN -0.6% 9% 156.8%
SUN PHARMACEUTICAL INDUSTRIES -0.9% -4.8% 50.2%
CIPLA 1.5% 0.1% 19.9%
DR REDDYS LABORATORIES -0.4% -8.2% 7.1%
ZYDUS LIFESCIENCES 0.6% -5.3% 51%
DIVIS LABORATORIES 3% 5.9% 65%
MANKIND PHARMA 0.6% 3.1% 34.4%
TORRENT PHARMACEUTICALS 4.3% -2.7% 54.2%
LUPIN -0.1% -4.4% 72.4%

FUNDAMENTAL ANALYSIS OF GUJARAT THEMIS BIOSYN

 
Fundamentals Score
[ Q(TTM): Sep2024, Y: Mar2024
Q : Last Qtr data
Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
]

Insights 💡 GUJTHEMIS is one of the top 35% companies with good fundamentals ! Discover More →

VALUATION OF GUJARAT THEMIS BIOSYN

 
Valuation Score
[As on : Nov 26,2024 ]

Ratio Standalone
P/E
P/B
P/S
67.39
P/E Calculated based on Trailing Twelve Months (TTM) Earnings of Rs 52.70 Cr
[Latest Qtr - Sep2024 - Standalone Results ]

17.64
P/B Calculated based on Book Value of Rs 201.38 Cr
[Latest Year - Mar2024 - Standalone Results ]

23
P/S Calculated based on Trailing Twelve Months (TTM) Revenues of Rs 0.00 Cr
[Latest Qtr - Sep2024 - Standalone Results ]

Financial Ratios →

Insights 💡 There are potential 9% undervalued companies ! Discover More →

FAIR VALUE OF GUJARAT THEMIS BIOSYN

 
Model Discount(-)/
Premium(+)
EV/EBIDTA
EV/Sales
Price/Sales
387%
810%
876%

Insights 💡 You can learn about various Valuation techniques to calculate Intrinsic Value
with our bestselling video course Value Investing - The Ultimate Guide
Take Me There →

SHARE PRICE MOMENTUM OF GUJARAT THEMIS BIOSYN



GUJARAT THEMIS BIOSYN vs SENSEX


Insights 💡 You can learn about Basics of Stock Marketing Investing
with our bestselling video course Stock Marketing Investing Simplified
Take Me There →

DEBT OF GUJARAT THEMIS BIOSYN

Year Debt/Equity ratio
Standalone Consolidated
2024
2023
2022
Avg_3yrs
0
0
0
-
-
-
-
-
[Last Annual Data : Mar2024]
Financial Ratios →

PLEDGED PROMOTER SHARES OF GUJARAT THEMIS BIOSYN

Pledged Promoter Shares
3.3 %
As on : Dec2023

If less than 25%

Good
If between 25% and 50% Neutral
If greater than 50% Bad
Shareholding Pattern →

QTRLY RESULTS OF GUJARAT THEMIS BIOSYN

Standalone Q-o-Q Y-o-Y
Revenue
Op Profit
Profit Before Tax
Profit After Tax
-10.59%
-17.03%
-20.54%
-20.17%
-12.21%
-7.97%
-15.95%
-15.75%
QtrlyTrend
-8
Latest Qtr: Sep2024
Quarterly Result Analysis →


GUJARAT THEMIS BIOSYN related INDICES

BSE Indices1W1M1Y
S&P BSE SMALL CAP 3.7% -0.2% 35.7%
S&P BSE MIDSMALLCAP 3.6% -0.5% 36.5%
S&P BSE HEALTHCARE 2.4% 1% 45.8%
S&P BSE ALLCAP -0.3% -3.5% 35.8%
No NSE index found

You may also like the below Video Courses


FAQ about GUJARAT THEMIS BIOSYN


Is GUJARAT THEMIS BIOSYN good for long term investment?

As on Nov 26,2024, the Fundamentals of GUJARAT THEMIS BIOSYN look Strong and hence it may be good for long term investment! See Financial Performance of GUJARAT THEMIS BIOSYN . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!

Is GUJARAT THEMIS BIOSYN UnderValued or OverValued?

As on Nov 26,2024, GUJARAT THEMIS BIOSYN is Over Valued based on the estimates of intrinsic value and hence may not be a good buying opportunity according to Share Valuation at this time!

What is the Intrinsic Value of GUJARAT THEMIS BIOSYN ?

As on Nov 26,2024, the Intrinsic Value of GUJARAT THEMIS BIOSYN is Rs. 35.83 estimated based on Median of the 3 historical models.
Fair Value [Median EV / EBIDTA Model] : Rs. 66.88
Fair Value [Median EV / Sales Model] : Rs. 35.83
Fair Value [Median Price / Sales Model] : Rs. 33.39
Estimated Median Fair Value of GUJARAT THEMIS BIOSYN : Rs. 35.83

The fair value of any stock is always subjective and should, in no way, be taken as a recommendation to buy/sell the same.

Is GUJARAT THEMIS BIOSYN trading at a Premium or Discount?

As on Nov 26,2024, GUJARAT THEMIS BIOSYN is trading at a Premium of 810% based on the estimates of Median Intrinsic Value!